Skip to main content

Table 1 Baseline demographic and clinical characteristics of the participants (N = 114)

From: Effects of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: a preliminary randomized controlled trial

Variables

True AA

(n = 38) (%)

Sham AA

(n = 38) (%)

Standard Care

(n = 38) (%)

Total

(n = 114) (%)

Homogeneity Statistics (p)

Age (Mean ± SD)

46.2 ± 7.1

47.9 ± 9.9

48.4 ± 9.3

47.5 ± 8.8

0.54

Education background

 Primary school

18 (47.4%)

19 (50.0%)

17 (44.7%)

54 (47.4%)

0.27

 Secondary school

6 (15.8%)

10 (26.3%)

8 (21.1%)

24 (21.1%)

 High school/technical school

11 (28.9%)

7 (18.4%)

5 (13.2%)

23 (20.2%)

 College diploma/university degree

3 (7.9%)

2 (5.3%)

8 (21.1%)

13 (11.4%)

Marital status

 Single

1 (2.6%)

0 (0.0%)

0 (0.0%)

1 (0.9%)

 > 0.99

 Married

37 (97.4%)

38 (100%)

38 (100%)

113 (99.1%)

Employment status

 Professional

8 (21.1%)

5 (13.2%)

6 (15.8%)

19 (16.7%)

0.91

 Manual work

8 (21.1%)

7 (18.4%)

7 (18.4%)

22 (19.3%)

 Housewife

17 (44.7%)

14 (36.8%)

16 (42.1%)

47 (41.2%)

 Admin/clerical

2 (5.3%)

4 (10.5%)

3 (7.9%)

9 (7.9%)

 Retired

1 (2.6%)

4 (10.5%)

4 (10.5%)

9 (7.9%)

 Other

2 (5.3%)

4 (10.5%)

2 (5.3%)

8 (7.0%)

Religious background

 Buddhist

13 (34.2%)

14 (36.8%)

11 (28.9%)

38 (33.3%)

0.32

 Christian

4 (10.5%)

0 (0.0%)

2 (5.3%)

6 (5.3%)

 None

21 (55.3%)

24 (63.2%)

25 (65.8%)

70 (61.4%)

Family monthly income

  < 3000 CNY

6 (15.8%)

8 (21.1%)

10 (26.3%)

24 (21.1%)

0.22

 3000–6000 CNY

15 (39.5%)

22 (57.9%)

16 (42.1%)

53 (46.5%)

 6001–10,000 CNY

13 (34.2%)

5 (13.2%)

11 (28.9%)

29 (25.4%)

  > 10,000 CNY

4 (10.5%)

3 (7.9%)

1 (2.6%)

8 (7.0%)

Medical insurance

 Free government medical service

3 (7.9%)

1 (2.6%)

4 (10.5%)

8 (7.0%)

0.23

 Social insurance

12 (31.6%)

14 (36.8%)

17 (44.7%)

43 (37.7%)

 New rural cooperative medical service

22 (57.9%)

17 (44.7%)

15 (39.5%)

54 (47.4%)

 Self-financed

1 (2.6%)

6 (15.8%)

2 (5.3%)

9 (7.9%)

Cancer Stage

 Stage I

5 (13.2%)

5 (13.2%)

5 (13.2%)

15 (13.2%)

0.43

 Stage II

19 (50.0%)

26 (68.4%)

20 (52.6%)

65 (57.0%)

 Stage III

14 (36.8%)

7 (18.4%)

13 (34.2%)

34 (29.8%)

Surgery

 Modified radical mastectomy

24 (63.2%)

30 (78.9%)

27 (71.1%)

81 (71.1%)

0.50

 Simple mastectomy

1 (2.6%)

2 (5.3%)

2 (5.3%)

5 (4.4%)

 Breast-conserving surgery

2 (5.3%)

0 (0.0%)

2 (5.3%)

4 (3.5%)

 Other

3 (7.9%)

1 (2.6%)

4 (10.5%)

8 (7.0%)

 NA

8 (21.1%)

5 (13.2%)

3 (7.9%)

16 (14.0%)

Chemotherapy combination

 AC/AC-T combination

15 (39.5%)

14 (36.8%)

12 (31.6%)

41 (36.0%)

0.99

 EC/EC-T/EC-D combination

20 (52.6%)

21 (55.3%)

22 (57.9%)

63 (55.3%)

 TC combination

2 (5.3%)

2 (5.3%)

2 (5.3%)

6 (5.3%)

 Other a

1 (2.6%)

1 (2.6%)

2 (5.3%)

4 (3.5%)

Antiemetic medication

 5-HT3 antagonists + dexamethasone

22 (57.9%)

23 (60.5%)

22 (57.9%)

67 (58.8%)

 > 0.99

 5-HT3 antagonists only

16 (42.1%)

15 (39.5%)

15 (39.5%)

46 (40.4%)

 Dexamethasone only

0 (0.0%)

0 (0.0%)

1 (2.6%)

1 (0.9%)

Risk factor for CINV

 Aged less than 50 years old

25 (65.8%)

23 (60.5%)

19 (50.0%)

67 (58.8%)

0.36

 History of morning sickness

26 (68.4%)

27 (71.1%)

19 (50.0%)

72 (63.2%)

0.12

 History of motion sickness

18 (47.4%)

16 (42.1%)

13 (34.2%)

47 (41.2%)

0.50

 History of labyrinthitis

1 (2.6%)

1 (2.6%)

1 (2.6%)

3 (2.6%)

 > 0.99

Number of risk factor for CINV

 3 risk factors or above

11 (28.9%)

7 (18.4%)

7 (18.4%)

25 (21.9%)

0.44

 Less than 3 risk factors

27 (71.1%)

31 (81.6%)

31 (81.6%)

89 (78.1%)

  1. This table is derived and modified from the original PhD thesis of Professor Jing-Yu (Benjamin) Tan [Tan, J. (2017). Effects of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: a preliminary randomized controlled trial. Doctoral dissertation, The Hong Kong Polytechnic University, Hong Kong.] [28]
  2. AA auricular acupressure, NA not applicable, SD standard deviation, CNY Chinese Yuan
  3. AC = doxorubicin + cyclophosphamide; T = paclitaxel; EC = epirubicin + cyclophosphamide; D = docetaxel; TC = cyclophosphamide + docetaxel; a = other less frequently used chemotherapy combinations with moderately-high to highly emetogenic potential, including pirarubicin plus cyclophosphamide combination and pirarubicin/epirubicin combined with other chemotherapeutic agents with low to moderate emetogenic risks, CINV chemotherapy-induced nausea and vomiting